When lung cancer treatment stops working, what happens next? New research reveals the answer may depend on how the cancer grows.

Then you have the fact that clinical trials often underrepresent minorities. This can lead to skewed AI models, with 80 ...

Researchers found an antibody that seems to play a role in people with better lung cancer prognoses, but turning it into a ...

And, if all goes well, over the next five years as well.

The vaccines subsector received a big fillip from Covid, but its potential extends far beyond combating pandemics. Dr Mike ...

For a breast cancer survivor who opts for reconstruction, the struggle doesn’t always end with a successful mastectomy: She must cope with a lack of sensation in the reconstructed breast. “Even if it ...

Even with breakthroughs, treatment for advanced squamous cell carcinoma is more complex. Patients often need more than one treatment. Many patients with this advanced cancer are cared for by a team of ...

AI tools designed to diagnose cancer from tissue samples are quietly learning more than just disease patterns. New research shows these systems can infer patient demographics from pathology slides, ...

Coherus Oncology, Inc. ( CHRS) 44th Annual J.P. Morgan Healthcare Conference January 13, 2026 1:30 PM EST Good morning everyone. It's still the morning. Thanks for joining us for another session at ...

New data show cancer survival has reached a record high — nearly 70% of patients now live at least five years after diagnosis ...

With an estimated 12,600 new cases of bladder cancer in Canada in 2025, plus almost 84,870 in the United States, ranking 5th ...

Among patients with advanced melanoma, long-term data have shown that a personalized mRNA cancer vaccine, when combined with ...